The Cardiovascular Center and Department of Internal Medicine, The University of Iowa Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA.
Heart Fail Rev. 2011 Mar;16(2):109-27. doi: 10.1007/s10741-010-9174-6.
The methods used to assess cardiac parasympathetic (cardiovagal) activity and its effects on the heart in both humans and animal models are reviewed. Heart rate (HR)-based methods include measurements of the HR response to blockade of muscarinic cholinergic receptors (parasympathetic tone), beat-to-beat HR variability (HRV) (parasympathetic modulation), rate of post-exercise HR recovery (parasympathetic reactivation), and reflex-mediated changes in HR evoked by activation or inhibition of sensory (afferent) nerves. Sources of excitatory afferent input that increase cardiovagal activity and decrease HR include baroreceptors, chemoreceptors, trigeminal receptors, and subsets of cardiopulmonary receptors with vagal afferents. Sources of inhibitory afferent input include pulmonary stretch receptors with vagal afferents and subsets of visceral and somatic receptors with spinal afferents. The different methods used to assess cardiovagal control of the heart engage different mechanisms, and therefore provide unique and complementary insights into underlying physiology and pathophysiology. In addition, techniques for direct recording of cardiovagal nerve activity in animals; the use of decerebrate and in vitro preparations that avoid confounding effects of anesthesia; cardiovagal control of cardiac conduction, contractility, and refractoriness; and noncholinergic mechanisms are described. Advantages and limitations of the various methods are addressed, and future directions are proposed.
本文回顾了评估人类和动物模型中心脏副交感神经(心迷走神经)活性及其对心脏影响的方法。基于心率的方法包括测量乙酰胆碱能受体(副交感神经张力)阻断后心率的反应、心率变异性(副交感神经调节)、运动后心率恢复率(副交感神经再激活),以及激活或抑制感觉(传入)神经时引起的心率反射性变化。增加心迷走神经活动和降低心率的兴奋性传入源包括压力感受器、化学感受器、三叉神经受体以及具有迷走神经传入的心肺受体亚群。抑制性传入源包括具有迷走神经传入的肺牵张感受器和具有脊髓传入的内脏和躯体感受器的亚群。评估心脏迷走神经控制的不同方法涉及不同的机制,因此为潜在的生理学和病理生理学提供了独特而互补的见解。此外,还描述了动物中心迷走神经活动的直接记录技术;使用避免麻醉混杂影响的去大脑和体外制剂;心脏迷走神经对心脏传导、收缩性和不应期的控制;以及非胆碱能机制。讨论了各种方法的优缺点,并提出了未来的发展方向。